Asset Comparison and Correlation
|S&P 500 vs Salix Pharmaceuticals Ltd.|
Assuming 30 trading days horizon, SP 500 is expected to generate 4.56 times less return on investment than Salix. But when comparing it to its historical volatility, S&P 500 is 2.42 times less risky than Salix. It trades about 0.32 of its potential returns per unit of risk. Salix Pharmaceuticals Ltd is currently generating about 0.59 of returns per unit of risk over similar time horizon. If you would invest 5,151 in Salix Pharmaceuticals Ltd on April 25, 2013 and sell it today you would earn a total of 888 from holding Salix Pharmaceuticals Ltd or generate 17.24% return on investment over 30 days.
Match-ups for SP 500
68% of all equities and portfolios perform better than Salix Pharmaceuticals Ltd. Compared with the overall equity markets, risk-adjusted returns on investments in Salix Pharmaceuticals Ltd are ranked lower than 32 (%) of all global equities and portfolios over the last 30 days.
Match-ups for Salix